Clinical Data
Sermorelin — Interactions & Safety Profile
2 contraindications3 known interactions⚠ Pregnancy warning
Medical Disclaimer
This safety information is for educational purposes only. Drug interactions can vary based on individual factors. Always consult a physician before combining compounds.
Contraindications
Active cancer or history of cancer
GH and IGF-1 are growth factors that may promote tumour growth.
Active pituitary tumours
GHRH stimulation may exacerbate pituitary pathology.
Drug Interactions
GlucocorticoidsModeratemoderate interaction
Glucocorticoids can blunt the GH response to GHRH stimulation.
May need to adjust sermorelin dose if on chronic corticosteroids.
Insulin / Diabetes medicationsModeratemoderate interaction
GH elevation affects glucose metabolism and may increase insulin resistance.
Monitor blood glucose; may need diabetes medication adjustment.
Thyroid medicationsMinorminor interaction
GH can affect T4→T3 conversion and may unmask central hypothyroidism.
Monitor thyroid function after starting GH-stimulating therapy.
Monitoring Required
- •IGF-1 levels (every 4-8 weeks initially)
- •Fasting glucose (GH affects glucose metabolism)
Pregnancy & Nursing
No adequate safety data. Avoid in pregnancy/breastfeeding.
⏳
Pending physician review — consult your provider before use.